Molecular therapy for Ischemic heart disease: Expression of E2F3 in bone-marrow derived cells mediates cardiac repair after myocardial infarction via down regulation of its target gene, 14/February/2015, 12.13 am

MiRNA-based Regenerative therapy for DM: p63-miR-130 pathway increases insulin-secreting cell mass and function via down regulation of its target genes, 14/February/2015, 11.23 am
February 14, 2015
Molecular therapy for NIDDM: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) inhibits gluconeogenesis and hyperglycemia via up regulation of Cyclin D1, 14/February/2014, 12.51 pm
February 14, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for Ischemic heart disease: Expression of E2F3 in bone-marrow derived cells mediates cardiac repair after myocardial infarction via down regulation of its target gene, 14/February/2015, 12.13 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that E2F3, by suppressing the expression of its target gene, it may promote cardiac repair after myocardial infarction.  Thus, pharmacological formulations encompassing “E2F3 activators  may be used to promote cardiac repair.

Amount: $ 300*

Undisclosed information: How E2F3 promotes cardiac repair after myocardial infarction

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.